Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20272946 | 0.84 | ALDH1A1 (0.44) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL8170243 | 0.83 | ALDH1A1 (0.54) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL162529 | 0.83 | ALDH1A1 (0.58) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL28910441 | 0.83 | ALDH1A1 (0.48) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL13156531 | 0.81 | ALDH1A1 (0.46) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL2386458 | 0.80 | ALDH1A1 (0.62) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL29524245 | 0.80 | ALDH1A1 (0.62) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL31242880 | 0.80 | ALDH1A1 (0.62) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL20272948 | 0.79 | ALDH1A1 (0.54) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| SCHEMBL13156534 | 0.79 | NPC1 (0.48) | ALDH1A1NPC1POLBRAB9ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063517-A | Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2024-05-24 | — | — | CN | claimed |
| US-20240074310-A1 | LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | claimed |
| CN-117596910-A | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-02-23 | — | — | CN | claimed |
| US-20220216419-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-07-07 | — | — | US | claimed |
| CN-118063517-A | Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240157322-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2024-05-16 | — | — | US | disclosed |
| US-20240149237-A1 | ACETOACETYL POLYMER - BASED MICROCAPSULES | FIRMENICH SA (CH) | 2024-05-09 | — | — | US | disclosed |
| CN-220755379-U | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240074310-A1 | LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| CN-117596910-A | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-4313396-A1 | ACETOACETYL POLYMER-BASED MICROCAPSULES | Firmenich SA (CH) | 2024-02-07 | — | — | EP | disclosed |
| EP-4313393-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | Firmenich SA (CH) | 2024-02-07 | — | — | EP | disclosed |
| US-20060154944-A1 | Novel tricyclic heterocycle compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1679309-A1 | ANTISTRESS DRUG AND MEDICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| EP-1666472-A1 | PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-06-07 | — | — | EP | disclosed |
| EP-1661879-A1 | DIPHENYL ETHER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1637521-A1 | NOVEL TRICYCLIC HETEROCYCLE COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-03-22 | — | — | EP | disclosed |
| US-4801590-A | ANGINA, ANTICANCER, CARDIOVASCULAR DISORDERS, HEADACHES, PSORIASIS, ASTHMA, ANTICOAGULANTS | BEIERSDORF AG (DE) | 1989-01-31 | — | — | US | disclosed |
| US-4119631-A | Penicillins and their preparation | E. MERCK, PATENTABTEILUNG (DE) | 1978-10-10 | — | — | US | disclosed |
| US-4031230-A | Novel penicillins and their preparation | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060154944-A1 | Novel tricyclic heterocycle compound | CYP11B1, CYP11B2, HCCS | ALDH1A1 1422/4885NPC1 707/4885POLB 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.